Medicare Enrolled

Dr. Ashraf Luqman, MD

Pulmonary Disease · Orange City, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1075 TOWN CENTER DR, Orange City, FL 32763
3869170333
In practice since 2006 (19 years)
NPI: 1326153016 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Luqman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Luqman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Luqman

Dr. Ashraf Luqman is a pulmonary disease in Orange City, FL, with 19 years in practice. Based on federal Medicare data, Dr. Luqman performed 3,278 Medicare services across 2,050 unique beneficiaries.

Between the years covered by Open Payments, Dr. Luqman received a total of $2,183 from 20 pharmaceutical and/or device companies across 63 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Luqman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 15% volume in FL$ $2,183 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,278
Medicare services
Top 15% in FL for pulmonary disease
2,050
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~173 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity859$95$135
Critical care, first 30-74 min511$172$363
Office visit, established patient (30-39 min)302$93$195
Test to determine lung volumes using sensors207$40$100
Test to measure expiratory airflow and volume changes before and after medication administration206$29$135
Test to examine how well the lungs exchange gases206$42$135
Initial hospital admission, high complexity200$132$266
Hospital follow-up visit, moderate complexity182$63$120
Advance care planning consultation, first 30 min140$63$120
Test for exercise-induced lung stress115$26$225
Office visit, established patient, complex (40-54 min)96$137$275
Critical care, each additional 30 minutes67$86$163
New patient office visit, complex (60-74 min)51$171$340
Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th50$25$45
Advance care planning, each additional 30 minutes48$56$110
Irrigation and suction of lung airways to obtain cells using an endoscope24$103$750
New patient office visit (45-59 min)14$110$255
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,183
Total received (2018-2024)
Avg $312/year across 7 years
Bottom 47% in FL for pulmonary disease
20
Companies
63
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,082 (95.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$101 (4.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$391
2023
$343
2022
$345
2021
$101
2020
$248
2019
$278
2018
$477

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$395
GENZYME CORPORATION
$195
Pulmonx Corporation
$190
Regeneron Healthcare Solutions, Inc.
$171
Boehringer Ingelheim Pharmaceuticals, Inc.
$160
Mallinckrodt Hospital Products Inc.
$149
Inari Medical, Inc.
$138
Ethicon Inc.
$123
Takeda Pharmaceuticals U.S.A., Inc.
$118
Gilead Sciences, Inc.
$114
Edwards Lifesciences Corporation
$104
GlaxoSmithKline, LLC.
$84
Sunovion Pharmaceuticals Inc.
$58
EKOS Corporation
$54
Philips Electronics North America Corporation
$38
Ceribell, Inc.
$33
Baxter Healthcare
$19
Paratek Pharmaceuticals, Inc.
$15
Grifols USA, LLC
$13
Electromed, Inc.
$13
Top 3 companies account for 35.8% of total payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · BEVESPI AEROSPHERE · BREO · BREZTRI · CHARTIS CATHETER · Ceribell Rapid Response EEG · DUPIXENT · EKOSONIC · EV1000 Clinical Platform · FASENRA · FLOWTRIEVER CATHETER · GLASSIA · Hillrom - Life 2000 Ventilation System · IMFINZI · LONHALA MAGNAIR · Monarch Platform · NUCALA · NUZYRA · OFEV · POCKET EEG DEVICE · Prolastin-C Liquid · S · SMARTVEST · STIOLTO RESPIMAT · TEZSPIRE · TRELEGY ELLIPTA · Utibron · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $67 per 100 Medicare services performed
Looking for a pulmonary disease in Orange City?
Compare pulmonary diseases in the Orange City area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
19
Per 100K population
3.3
County median income
$66,581
Nearest hospital
ADVENTHEALTH FISH MEMORIAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Luqman is a clinical cardiology specialist, with above-average Medicare volume (top 15% in FL), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Luqman experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Luqman performed 859 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Luqman receive payments from pharmaceutical companies?
Yes. Dr. Luqman received a total of $2,183 from 20 companies across 63 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Luqman's costs compare to other pulmonary diseases in Orange City?
Dr. Luqman's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Luqman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →